TNF-α-Mediated Lung Cytokine Networking and Eosinophil Recruitment in Pulmonary Fibrosis

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 954-959

  Zhang, Kai ^a   Gharaee Kermani, Mehrnaz ^a   McGarry, Bridget ^a   Remick, Daniel ^a   Phan, Sem H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYTOKINE; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CBA MOUSE; DRUG EFFECT; EOSINOPHIL; FEMALE; LUNG FIBROSIS; METABOLISM; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLEOMYCIN; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; EOSINOPHILS; FEMALE; INTERLEUKIN-5; MICE; MICE, INBRED CBA; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031568010     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Spry, C. J. F., A. B. Kay, and G. J. Gleich. 1992. Trend: eosinophils. Immunol Today 12:384.
2. 1 by eosinophils during cutaneous wound healing in the hamster. Am. J. Pathol. 143:130.
3. Wong, D. T. W., P. F. Weller, S. J. Galli, H. Elovic, T. H. Rand, G. T. Galagher, T. Chiang, M. Y. Chou, K. Matossian, J. McBride, and R. Todd. 1990. Human eosinophils express transforming growth factor α. J Exp. Med. 172:673.
4. Ohno, I., R. Lea, S. Finotto, J. Marshall, J. Denbury, J. Dolovich, J. Gauldie, and M. Jordana. 1993. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am. J. Respir. Cell Mol. Biol. 5:505.
5. Zhang, K., M. Gharaee-Kermani, M. L. Jones, J. S. Warren, and S. H. Phan. 1994. Monocyte chemoattractant protein-1 gene expression in bleoraycin-induced pulmonary fibrosis. J. Immunol. 128:487.
6. Zhang, K., K. C. Flanders, and S. H. Phan. 1995. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:352.
7. White, D. A., M. G. Kris, and D. E. Stover. 1987. Bronchoalveolar lavage cell populations in bleomycin lung toxicity. Thorax 42:551.
8. Noguchi, H., G. M. Kephart, T. V. Colby, and G. J. Gleich. 1992. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am. J. Pathol. 140:521.
9. Powell, P. P., M. Klagsbrun, J. A. Abraham, and R. C. Jones. 1993. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143:784.
10. Peterson, M. W., M. Monick, and G. W. Hunninghake. 1987. Prognostic role of eosinophils in pulmonary fibrosis. Chest 92:51.
11. Hallgren, R., L. Bjermer, R. Lundgren, and P. Venge. 1989. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am, Rev. Respir. Dis. 139:373.
12. Allen, J. N., W. B. Davis, and E. R. Pacht. 1990. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am. Rev. Respir. Dis. 142: 642.
13. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin-5 and granulocyte macrophage-colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
14. Kita, H., T. Ohnishi, Y. Okubo, D. Weiler, J. S. Abrams, and G. J. Gleich. 1991. Granulocyte/macrophage-colony stimulating factor and interleukin-3 release from human peripheral blood eosinophils and neutrophils. J. Exp. Med. 174:745.
15. Hamid, Q., J. Barkans, Q. Meng, S. Ying, J. S. Abrams, A. B. Kay, and R. Moqbel. 1992. Human eosinophils synthesize and secrete interleukin-6. Blood 80:1496.
16. Braun, R. K., M. Franchini, F. Erard, S. Rihsn I. J. M. DeVriesn K. Blaser, T. T. Hansel, and C. Walker. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur. J. Immunol. 23:956.
17. Costa, J. J., K. Matossian, W. J. Beil, D. T. W. Wong, J. R. Gordon, A. M. Dvorak, P. F. Weller, and S. J. Galli. 1993. Human eosinophils can express the cytokines TNFα and MIP-1α. J. Clin. Invest. 91:2673.
18. Lim, K., H.-C. Wan. M. Resnick, D. T. W. Wong, W. W. Cruikshank, H. Kornfeld, D. M. Center, and P. F. Weller. 1995. Human eosinophils release the lymphocyte and eosinophil active cytokines. RANTES and lymphocyte chemoattractant factor (LCF). Int. Arch. Allergy Immunol. 107:342.
19. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor-α/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655.
20. Piguet, P. F., and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7:515.
21. Miyazaki, Y., K. Araki, C. Vesin, I. Garcia, Y. Kapanci, J. A. Whitsett, P. F. Piguet, and P. Vassalli. 1995. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96:250.
22. Lukacs, N. W., R. M. Stricter, S. W. Chensue, M. Widmer, and S. L. Kunkel. 1995. TNFα mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154:5411.
23. Zeck-Kapp, G., W. Czech, and A. Kapp. 1994. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology: comparison with IL-5. Exp. Dermatol. 3:176.
24. Mauviel, A., M. Daireaux, F. Redini, P. Galera, G. Loyau, and J.-P. Pujol. 1988. Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett. 236:47.
25. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycininduced pulmonary fibrosis. Exp. Lung Res. 18:29.
26. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin-5. J. Exp. Med. 172:1425.
27. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, Y. Kanai, J.-I. Miyazaki, G. Usuku, K.-I. Yamamura, and K. Takatsu. 1991. Transgenic mice expressing a B-cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429.
28. Sanderson, C. J. 1992. Interleukin-5, eosinophils and disease. Blood 79:3101.
29. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
30. Coletti, L. M., D. G. Remick, G. D. Burtch, S. L. Kunkel, R. M. Stricter, and D. A. Campbell, Jr. 1990. Role of tumor necrosis factor-alpha in the pathophysiological alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. lnvest. 85:1936.
31. Eskandari, M. K., G. Bolgos. C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia, J. Immunol. 148:2724.
32. Remick, D. G., P. Manohar, G. Bolgos, J. Ropdriguez, L. Moldawer, and G. Wollenberg. 1995. Blockade of tumor necrosis factor reduces lipopolysaccharide iethality, but not the lethality of cecal ligation and puncture. Shock 4:89.
33. Grouls, V., and B. Helpap. 1981. Selective staining of eosinophils and their immature precursors in tissue sections and autoradiographs with Congo red. Stain Technol. 56:323.
34. Hume, D. A., V. H. Perry, and S. Gordon. 1984. The mononuclear phagocyte system of the mouse defined by immunohistochemical localizations of antigen F4/80: macrophages associated with epithelia. Anal. Rec. 210:503.
35. Lee, S.-H., P. M. Starky, and S. Gordon. 1985. Quantitative analysis of total macrophage content in adult mouse tissues. J. Exp. Med. 161:475.
36. Phan, S. H., and S. L. Kunkel. 1986. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguiaretic acid: the role of alveolar macrophages activation and mediator production. Am. J. Pathol. 124:343.
37. Campell, H. D., W. Q. Tucker, Y. Hort, M. E. Martinson, G. Mayo, E. J. Clutterbuck, C. J. Sanderson, and I. G. Young. 1987. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin-5). Proc. Natl. Acad. Sci. USA 84:6629.
38. Durham, S. R., S. Ying, V. A. Varneyn M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. A. Hamid. 1992. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390.
39. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun. W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophilactive cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901.
40. Nagai, H., S. Yamaguchi, N. Inagaki, N. Tsurouka, Y. Hitoshi, and K. Takatsu. 1993. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci. 53:243.
41. Gulbenkian, A. R., R. W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. Kung, F. Payvandi, L. Sullivan, J. A. Zurcher, and A. S. Watnick. 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:263.
42. Chand, N., J. E. Harrison, S. Rooney, J. Pillar, R. Jakubicki, K. Nolan, W. Diamantis, and R. D. Sofia. 1992. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211:121.
43. Mauser, P. J., A. Pitman, X. Fernandez, A. Zurcher, T. T. Kung, A. S. Watnick, R. W. Egan, W. Kreutner, and G. K. Admas III. 1993. Inhibitory effect of the TRFK-5 and anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623.
44. Van Oosterhout, A. J. M., A. R. C. Ladenius, H. F. J. Savelkoul, I. Vanark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548.
45. Kung, T. T., D. M. Stelts, J. A. Zurcher, G. K. Adams III, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, and R. W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol Biol. 13:360.
46. Yang, J. P., and Renzi, P. M. 1993. Interleukin-2 and lymphocyte-induced eosinophil proliferation and survival in asthmatic patients. J. Allergy Clin. Irnmunol. 91:792.
47. Warren, D. J., and M. A. S. Moore. 1988. Synergism among interleukin-1, interleukin-3 and interleukin-5 in the production of eosinophils from primitive hemopoietic stem cells. J. Immunol. 140:94.
48. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
49. Das, A. M., T. J. Williams, R. Lobb, and S. Noursbaugh. 1995. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea pig model. Immunology 84:41.